Upload
spark123
View
217
Download
0
Embed Size (px)
Citation preview
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 1/15
Presented By:
VarunViralMilan
Paresh
Kirit
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 2/15
Core strength of IndianIndustry
Disease patternAlternative medicinePatents
DoctorsHealth insuranceHealthcare infrastructureInformation technology
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 3/15
MNC-Domestic
Competition
MNC-Domestic
Collaboration
CHANGING FACE OF INDIAN PHARMA
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 4/15
Growth in disposable incomes & the
number of middle-class households
Expansion of medical infrastructure
Greater penetration of health insurance
Rising prevalence of chronic diseases
Adoption of product patents
Aggressive market penetration
Debut of organized retail chains
3.4 3.9
6.1
20
4.6
2000 2002 2004 2006 2015
RETAIL PHARMACEUTICAL MARKET IN INDIA
US $ billion
Source: India Pharma 2015,
McKinsey & Co
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 5/15
Intensity of Rivalry amongexisting competitors
•Lower fixed cost and highworking capital.
•Highly competitive
• Top five players have mere18% of market share•Duplicate medicines
Suppliers’ BargainingPower
Volume benefit occur
Inputs standard,available locally
Numerous suppliersswitching cost low
Suppliers can go forforward integration
Raw material costconstitute more than50% of the totalexpenses Pressure from Substitute
Products
•No substitute for the
medicines
•Biotechnology is a threat to
Buyers’ BargainingPower
•End consumers do not
have bargaining power
•Brand identity existsbut It’s in the hands of influencer (Doctors)
•Rice sensitivity is less
•Highly fragmentedmarket, so buyerconcentration v/sindustry is low
Threat of New Entrants
•Very low Barrier to entry
•Government policessupportive for entry butprice regulation exists.
•Economies of scale exists
•Proprietary technology andproduct will exist after 2005
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 6/15
1. Product- Portfolio relatedThe ability to be the first to enter the marketNew product for existing Geographies and Existing Products for
New GeographiesRight kind of portfolio mix as per the prevalent disease patternRight positioning
2. Well- trained sales force
3. Integration to widen business opportunity
4. R & D effort to provide competitive advantage
5. Information technology to derive cost advantage & to be
customer responsive
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 7/15
6. Good manufacturing practices to provide
competitive advantage in terms of quality
7. Strong over-the-counter(OTC) brands
8. Exports- allopathic & Ayurvedic products
9. Strategic Alliance & Acquisitions
10. Business Design & Strategy
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 8/15
Methods Awareness Comprehension Conviction Action
Journal advertising 1 2 2 2
Direct mailing, couriers 1 1 2 2
Promotional trials 1 1 2 3
Conferences and symposia 1 1 2 3
Clinical trials 4 2 2 1
Samples 1 4 4 1
Gifts 1 4 4 1
Newspaper advertisement 1 2 4 2
Free stand-alone
supplements
1 1 1 3
Telemarketing 1 2 4 4
Conference videos 1 1 1 3Video Magazines 1 2 3 4
Audio cassettes - - - -
Television 1 4 2 1
Group detailing 1 2 2 4
1-Most Useful; 2-Useful; 3-Not Useful; 4-Least Useful
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 9/15
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 10/15
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 11/15
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 12/15
High Employee turnover compare to other sectorsretention Strategies (Mfg. & Mkt.)Employee Development Program
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 13/15
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 14/15
8/14/2019 Pharma strategies
http://slidepdf.com/reader/full/pharma-strategies 15/15